FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Care and Connection That Matter

Access to care, trusted guidance, and meaningful programs that support individuals and families—every step of the way.

Camp Courageous

The application for this session will be completed through Camp Courageous's application site. Please contact hdepriest@mdausa.org if you are interested in receiving the application link once it's available.

Find MDA
in your Community